Videos
Peer-to-Peer Clinical Conversations
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR – Beyond the Abstract
Patient perception of meaningful reductions in bothersome symptoms of overactive bladder (OAB) is lacking.
VIEW
The Effects of Vibegron on Ambulatory Blood Pressure in Patients With Overactive Bladder – Michael A. Weber
Michael A. Weber
Diane Newman is joined by Michael Weber discussing a novel medication for the treatment of overactive bladder and a study Dr Weber presented at the AUA 2021 Annual Meeting.
VIEW
Beyond the Abstracts
Sleep Disorders and Cancer: State of the Art and Future Perspectives – Beyond the Abstract
Urethroplasty Outcomes for Urethral Stricture Disease in Patients with Neurogenic Bladder or Bladder Dysfunction Requiring Clean Intermittent Catherization – Beyond the Abstract
Conference Coverage
SUFU 2022: Trends in Overactive Bladder Therapy Utilization: An Evaluation of the Impact of Clinical Care Pathways and Practice Guidelines
SUFU 2022: Bladder Hotline: The Impact of COVID-19 and Telemedicine on Empiric UTI Treatment in Women
SUFU 2022: The Bladder Inhibitory Effects of Saphenous Nerve Stimulation are Mediated Via A Supraspinal Pathway in Anesthetized Rodents
SUFU 2022: A Closer Look: Outcomes of Intradetrusor Injection of OnabotulinumtoxinA (BTX-A) in the Elderly Population.
SUFU 2022: Urinary Tract Infection on Social Media: Examining YouTube Content As a Source of Patient Educational Information
Articles
Editor Selected Abstracts and Commentaries

URINARY INCONTINENCE

Technical Update No. 433: eHealth Solutions for Urinary Incontinence among Women.

Evaluation of urinary continence status and its influence on quality of life after gyneco-oncological treatment of female pelvic malignancies at an oncological center.

STRESS INCONTINENCE

Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up.

Urologic latency time during uroflow stop test with electromyography: an incontinence detector in rehabilitation after robotic radical prostatectomy.
Establishment and validation of a risk prediction model for postpartum stress urinary incontinence based on pelvic floor ultrasound and clinical data.
Manual Physiotherapy Combined with Pelvic Floor Training in Women Suffering from Stress Urinary Incontinence and Chronic Nonspecific Low Back Pain: A Preliminary Study.

INTERSTITIAL CYSTITIS

Multimodal Treatment with Cognitive Behavioral Therapeutic Intervention Plus Bladder Treatment Is More Effective than Monotherapy for Patients with Interstitial Cystitis/Bladder Pain Syndrome-A Randomized Clinical Trial.

Stimulated whole blood cytokine/chemokine responses are associated with interstitial cystitis/bladder pain syndrome phenotypes and features of nociplastic pain: a MAPP research network study.

OVERACTIVE BLADDER

Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis.

Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms.
The detection of urinary viruses is associated with aggravated symptoms and altered bacteriome in female with overactive bladder.

POST-PROSTATECTOMY INCONTINENCE

Effect of pelvic floor muscle training on urinary incontinence after radical prostatectomy: An umbrella review of meta-analysis and systematic review.

Prediction of recovery time of urinary incontinence following robot-assisted laparoscopic prostatectomy.

NEUROGENIC BLADDER

Robotic versus open cystectomy with ileal conduit for the management of neurogenic bladder: a comparative study.

Neurogenic Lower Urinary Tract Dysfunction in the First Year After Spinal Cord Injury: A Descriptive Study of Urodynamic Findings.
Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson’s Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson’s disease using a self-contained wearable device.